All news

Pfizer stock: BofA raises target for Pfizer stock to USD 29.00

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Bank of America has raised its price target for Pfizer stock (PFE) to USD 29.00 from USD 27.00, maintaining a Neutral rating. This adjustment comes after Pfizer reported second-quarter 2026 revenue of USD 15.03 billion, an operational increase of 1.00 percent year-over-year. Despite the raised target, it remains below Pfizer's current NYSE price of USD 29.85 as of October 21, 2026.

Read original source

PFE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.